Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Phreesia To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Phreesia between May 8, 2025 and March 30, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983- 9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - June 28, 2026) - ...

公司事件与诉讼背景 - 律师事务所Faruqi & Faruqi正在调查针对Roblox Corporation的潜在索赔，并提醒投资者在2026年8月7日前寻求成为联邦证券集体诉讼的首席原告 [2] - 诉讼指控公司在2025年10月30日至2026年4月30日期间，向投资者做出了虚假和误导性陈述，并/或隐瞒了重大不利事实 [5] 公司具体指控与披露 - 指控的核心是公司隐瞒了年龄验证推广将导致增长显著放缓、平台内沟通减少、应用商店评分降低，并最终损害其有机增长潜力 [5][10] - 2026年4月30日，公司公布了2026财年第一季度业绩，大幅下调了预订量增长指引至8-12%，并下调了利润率预期 [6] - 公司披露年龄验证的采用率仅从上一季度末的45%提升至全球日活跃用户的51%，其对用户参与度和有机增长的影响远超管理层此前暗示的程度 [6][10] 市场反应与财务影响 - 业绩公布后，Roblox普通股价格从2026年4月30日的收盘价每股55.26美元，暴跌至2026年5月1日的每股45.13美元，单日跌幅约18.33% [7][10] 诉讼参与资格与程序 - 在2025年10月30日至2026年4月30日期间购买或获得Roblox证券并遭受财务损失的投资者，可能有资格参与此次集体诉讼 [11] - 首席原告是由法院指定的、在本案中拥有最大经济利益的投资者，代表全体集体成员指导和监督诉讼 [8][12] - 寻求被任命为首席原告的截止日期是2026年8月7日 [2][12]

Bitcoin ( CRYPTO:BTC ) transformed from a niche digital asset into a mainstream investment over the past decade, and few people did more to accelerate that shift than Michael Saylor. ...

ABB Ltd. ( ABBNY ) is no longer simply a European diversified industrial with an acceptable automation brand. I see a stronger bull case for ABB as being one of the few "clean" ways to invest in "AWS Certified AI Practitioner Early Adopter"I am a DevOps Engineer for a major, wholly owned subsidiary of a large-cap Fortune 500. I have been the primary driver of Anthropic-based tooling in our company's division, and have successfully pushed for the division-wide integration of tools like Claude Code via AWS Be ...

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that Badger Meter's strong financial results reflected "ongoing favorable industry trend ...

Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Embecta To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Embecta between November 25, 2025 and May 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - June 28, 2026) - ...

Shares of Capri Holdings Ltd. NYSE: CPRI have lost 65% of their value over the past five years, weighed down by a failed merger, weakening luxury demand, and declining sales across its brands. But with the recent sale of its Versace brand, improving profitability, and the company forecasting a return to growth, there are signs the turnaround may be gaining traction. Get Capri alerts: Tapestry Deal Collapse Sent Shares Tumbling Much of Capri's struggles over the last several years can be traced to its failed ...

Get started with a Free Two-Week Trial and take a look at our top ideas across our exclusive income-focused portfolios. With a focus on REITs, ETFs, Preferreds, and Dividend Champions across asset classes, members gain complete access to our research and our suite of trackers and portfolios targeting premium dividend yields up to 10%. Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next ...

Millions of older Americans in Medicare are about to gain access to obesity drugs for the first time — but that landmark shift may be flying under the radar for many of them. Starting Wednesday, eligible beneficiaries can get obesity drugs through Medicare's new Bridge demonstration program for a monthly copay of just $50. The coverage marks a long-sought victory for patients, physicians and obesity advocates who have pushed for broader access to the blockbuster treatments from Novo Nordisk and Eli Lilly, w ...